Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationHodgkin DiseaseMultiple MyelomaMelphalanGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeStem CellsRemission InductionHematologic NeoplasmsSalvage TherapyMyeloablative AgonistsLymphoma, Non-HodgkinRecurrenceDisease-Free SurvivalBone Marrow TransplantationCyclophosphamideEtoposideSurvival RateLymphomaBusulfanCytarabineHematopoietic Stem Cell MobilizationRetrospective StudiesSurvival AnalysisTransplantation ChimeraVincristineWhole-Body IrradiationGraft SurvivalCarmustineHematopoietic Stem CellsTissue DonorsThiotepaLymphoma, FollicularBone Marrow PurgingLymphoma, Mantle-CellPrognosisLiver TransplantationFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedGraft vs Leukemia EffectAmyloidosisAntigens, CD34DoxorubicinLeukemia, Myeloid, AcuteMesenchymal Stem Cell TransplantationLymphoma, B-CellTime FactorsCord Blood Stem Cell TransplantationLymphoma, Large B-Cell, DiffuseNeoplasm, ResidualBoronic AcidsDexamethasoneVidarabineHistocompatibility TestingPyrazinesLymphoma, T-Cell, PeripheralAntineoplastic AgentsImmunosuppressive AgentsMyelodysplastic SyndromesAntineoplastic Agents, AlkylatingGraft vs Tumor EffectGranulocyte Colony-Stimulating FactorPrednisoneCell TransplantationThalidomideLeukemiaAutograftsKidney TransplantationEmbryonic Stem CellsLeukapheresisLymphocyte TransfusionIfosfamideHistocompatibilityInduction ChemotherapyPodophyllotoxinAdult Stem CellsReed-Sternberg CellsSiblingsPrecursor Cell Lymphoblastic Leukemia-LymphomaT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsMaintenance ChemotherapyAcute DiseaseLeukemia, MyeloidFatal OutcomeProspective StudiesNeoplasms, Second PrimaryHepatic Veno-Occlusive DiseaseAntilymphocyte SerumAntibodies, MonoclonalLymphocyte DepletionChimerism